They sustained that the therapeutic effect of BoNT-A in pompholyx in not only explained by its anhidrotic effect, but it is also due its inhibition of substance P. In 2007, other 2 cases of palmar pompholyx improved after BoNT-A treatment for palmar hyperhidrosis are described [102]. The gene discussed is TAC1; the disease is Hyperhidrosis.